0.5264
price up icon2.71%   0.0139
after-market Handel nachbörslich: .58 0.0536 +10.18%
loading
Schlusskurs vom Vortag:
$0.5125
Offen:
$0.52
24-Stunden-Volumen:
110.68K
Relative Volume:
0.60
Marktkapitalisierung:
$2.23M
Einnahmen:
$502.40K
Nettoeinkommen (Verlust:
$-7.91M
KGV:
-0.0528
EPS:
-9.972
Netto-Cashflow:
$-4.32M
1W Leistung:
+2.04%
1M Leistung:
-45.28%
6M Leistung:
-78.60%
1J Leistung:
-90.34%
1-Tages-Spanne:
Value
$0.5126
$0.5559
1-Wochen-Bereich:
Value
$0.4751
$0.5559
52-Wochen-Spanne:
Value
$0.45
$6.00

60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile

Name
Firmenname
60 Degrees Pharmaceuticals Inc
Name
Telefon
202-327-5422
Name
Adresse
1025 CONNECTICUT AVENUE NW, WASHINGTON
Name
Mitarbeiter
3
Name
Twitter
Name
Nächster Verdiensttermin
2025-08-15
Name
Neueste SEC-Einreichungen
Name
SXTP's Discussions on Twitter

Vergleichen Sie SXTP mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
SXTP
60 Degrees Pharmaceuticals Inc
0.5264 2.17M 502.40K -7.91M -4.32M -9.972
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
463.86 119.17B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
796.55 84.19B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
398.29 52.77B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
788.49 48.98B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
175.97 36.31B 447.02M -1.18B -906.14M -6.1812

60 Degrees Pharmaceuticals Inc Aktie (SXTP) Neueste Nachrichten

pulisher
Jan 09, 2026

Will 60 Degrees Pharmaceuticals Inc. Equity Warrant stock benefit from AI adoptionEarnings Beat & AI Forecasted Stock Moves - ulpravda.ru

Jan 09, 2026
pulisher
Jan 09, 2026

Shorts Report: Will 60 Degrees Pharmaceuticals Inc. stock benefit from AI adoption2025 Earnings Surprises & Real-Time Stock Price Movement Reports - ulpravda.ru

Jan 09, 2026
pulisher
Jan 08, 2026

What risks investors should watch in 60 Degrees Pharmaceuticals Inc. stockPortfolio Return Report & Fast Entry High Yield Stock Tips - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Can 60 Degrees Pharmaceuticals Inc. Equity Warrant stock maintain growth trajectoryDividend Hike & Verified Entry Point Detection - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Why 60 Degrees Pharmaceuticals Inc. Equity Warrant stock appeals to analysts2025 Valuation Update & Weekly High Potential Stock Alerts - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Movement Recap: Is 60 Degrees Pharmaceuticals Inc. stock vulnerable to regulatory risksJuly 2025 Intraday Action & Weekly Setup with ROI Potential - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Is 60 Degrees Pharmaceuticals Inc. stock a top pick in earnings seasonEarnings Recap Summary & Verified Technical Signals - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Will 60 Degrees Pharmaceuticals Inc. Equity Warrant stock outperform Nasdaq indexMarket Activity Recap & Weekly Return Optimization Plans - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Published on: 2026-01-09 01:34:54 - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Will 60 Degrees Pharmaceuticals Inc. stock benefit from AI adoptionEarnings Overview Report & High Yield Equity Trading Tips - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Is 60 Degrees Pharmaceuticals Inc. stock a top momentum playJuly 2025 Analyst Calls & Long Hold Capital Preservation Plans - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Published on: 2026-01-08 21:47:54 - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Will 60 Degrees Pharmaceuticals Inc. Equity Warrant stock deliver long term returnsJuly 2025 Short Interest & Safe Capital Growth Tips - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Published on: 2026-01-08 20:08:34 - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Will 60 Degrees Pharmaceuticals Inc. stock deliver consistent dividendsWeekly Trade Report & Long Hold Capital Preservation Tips - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Processa Pharmaceuticals and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Progress Index

Jan 08, 2026
pulisher
Jan 08, 2026

60 Degrees Pharma outlines growth strategy in investor webinar - TipRanks

Jan 08, 2026
pulisher
Jan 08, 2026

60 Degrees Pharmaceuticals, Inc. Updates on Clinical Development and Regulatory Strategy - TradingView — Track All Markets

Jan 08, 2026
pulisher
Jan 06, 2026

Why 60 Degrees Pharmaceuticals Inc. Equity Warrant stock appeals to dividend seekers2026 world cup usa national team final star players transition play group prediction tactical review - ulpravda.ru

Jan 06, 2026
pulisher
Jan 05, 2026

Enlivex Therapeutics and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Jackson Sun

Jan 05, 2026
pulisher
Jan 02, 2026

12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Jan 02, 2026
pulisher
Dec 30, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Dec 30, 2025
pulisher
Dec 30, 2025

60 Degrees Pharmaceuticals Inc. (NASDAQ:SXTP) Sees Large Growth in Short Interest - Defense World

Dec 30, 2025
pulisher
Dec 29, 2025

60 Degrees Pharmaceuticals, Inc. Confirms Continuation of B-FREE Study to Assess ARAKODA® for Chronic Babesiosis Treatment - Quiver Quantitative

Dec 29, 2025
pulisher
Dec 29, 2025

60 Degrees Pharmaceuticals Announces Detection of Babesia - GlobeNewswire

Dec 29, 2025
pulisher
Dec 29, 2025

60 Degrees Pharmaceuticals Announces Detection of Babesia Infection in 24 Percent of Patients Presenting with Chronic Fatigue in Peer-Reviewed, Sponsored Study at NC State - Sahm

Dec 29, 2025
pulisher
Dec 29, 2025

Tick-borne parasite found in 1 in 4 people with chronic fatigue in new study - Stock Titan

Dec 29, 2025
pulisher
Dec 28, 2025

60 Degrees Pharmaceuticals and NDT Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Coloradoan

Dec 28, 2025

Finanzdaten der 60 Degrees Pharmaceuticals Inc-Aktie (SXTP)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

60 Degrees Pharmaceuticals Inc-Aktie (SXTP) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
DOW GEOFFREY S
President and CEO
Dec 10 '25
Buy
0.95
9,350
8,886
46,335
DOW GEOFFREY S
President and CEO
Dec 11 '25
Buy
0.92
3,613
3,318
49,948
XU CHERYL
Director
Jun 03 '25
Buy
2.88
5,000
14,410
15,816
$106.87
price up icon 0.90%
$34.26
price up icon 1.87%
$118.64
price up icon 10.48%
$99.85
price up icon 1.01%
biotechnology ONC
$337.89
price up icon 5.47%
$175.97
price up icon 3.35%
Kapitalisierung:     |  Volumen (24h):